Target Price | €60.62 |
Price | €63.95 |
Deviation |
5.21%
register free of charge
|
Number of Estimates | 17 |
17 Analysts have issued a price target Carl Zeiss Meditec 2026 .
The average Carl Zeiss Meditec target price is €60.62.
This is
5.21%
register free of charge
€90.00
40.73%
register free of charge
€41.00
35.89%
register free of charge
|
|
A rating was issued by 17 analysts: 7 Analysts recommend Carl Zeiss Meditec to buy, 9 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Carl Zeiss Meditec stock has an average upside potential 2026 of
5.21%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 2.07 | 2.18 |
1.11% | 5.45% | |
EBITDA Margin | 17.59% | 17.80% |
15.88% | 1.18% | |
Net Margin | 8.52% | 7.05% |
37.46% | 17.22% |
17 Analysts have issued a sales forecast Carl Zeiss Meditec 2025 . The average Carl Zeiss Meditec sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Carl Zeiss Meditec EBITDA forecast 2025. The average Carl Zeiss Meditec EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Carl Zeiss Meditec Analysts have issued a net profit forecast 2025. The average Carl Zeiss Meditec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 2.01 | 1.76 |
38.15% | 12.44% | |
P/E | 36.43 | |
EV/Sales | 2.86 |
13 Analysts have issued a Carl Zeiss Meditec forecast for earnings per share. The average Carl Zeiss Meditec EPS is
This results in the following potential growth metrics and future valuations:
Carl Zeiss Meditec...
Analyst | Rating | Action | Date |
---|---|---|---|
HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Jan 05 2025 |
DZ BANK |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
EQUITA SIM |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
EQUI.TS |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
Analyst Rating | Date |
---|---|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Jan 05 2025 |
Locked
DZ BANK:
Locked
➜
Locked
|
Dec 18 2024 |
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Dec 17 2024 |
Locked
EQUITA SIM:
Locked
➜
Locked
|
Dec 15 2024 |
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Dec 15 2024 |
Locked
EQUI.TS:
Locked
➜
Locked
|
Dec 12 2024 |
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Dec 11 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.